FiercePharma reporter Noah Higgins-Dunn is returning to CNBC.com to cover pharmaceuticals and health.
He had joined FiercePharma earlier this year. He will start at CNBC next week.
Higgins-Dunn was a digital associate for CNBC.com covering the coronavirus. As a health and science reporter, he has covered breaking national news from the Trump administration and pharmaceutical companies racing to develop and produce COVID-19 therapeutics and vaccines.
His reporting on the opportunity gap within a mid-Missouri school district won two awards from the Missouri Press Association for best local business coverage and feature writing. He has also won a Missouri APME Award for Spot News from The Associated Press.
Higgins-Dunn graduated magna cum laude from the University of Missouri in 2019, earning a bachelor’s degree in journalism with an emphasis in business and economics reporting and a minor in business.
Wall Street Journal reporter Hannah Miao is moving to Singapore to cover the China economy.…
Financial Times reporter Simon Foy is now covering European banks. He has been covering accounting for the…
Debtwire, the leading provider of global fixed income news, analysis and data for more than…
Amber Kanwar, an anchor for BNN Bloomberg in Canada, is departing at the end of…
Moody's Ratings has promoted Yvette Kantrow to senior vice president and editor in chief. She has been…
Politico reporter Clare Fieseler is leaving the news organization to take on some ocean reporting projects. She…